Exclusive BreastfeedingEAME_FAPNCT07046741
Status Report on Exclusive Breastfeeding and Predictive Factors at Martigues Hospital
An observational study of Exclusive Breastfeeding, run by Centre Hospitalier de Martigues at 1 site in France.
Trial summary
Evaluate the prevalence of exclusive breastfeeding at M3 within the Martigues CH. Read more about this study
- Who is it for?
- Ages 18 to 60 years, women only
- Conditions the study is for
- Exclusive Breastfeeding
- How many people
- 309 participants
- Where
- 1 siteFrance
- Study dates
- 5 Aug 2024to 16 Sep 2025
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- Women only
- No healthy volunteers
- Adult
Study population: Women practicing exclusive breastfeeding from the birth of the newborn
Who may be able to join
- Woman aged 18 and over
- Having given birth to a healthy child (or multiples) regardless of the number of weeks of amenorrhea
- Women practicing exclusive breastfeeding from the birth of the newborn
- Able to speak, read and understand French
- Having given oral consent
Who cannot join
- Minor mothers
- Refusal of consent
- Mothers wishing to practice artificial breastfeeding upon leaving the maternity ward will be excluded in M1 and M3
- Women who have changed their mind about exclusive breastfeeding during their maternity stay will be excluded
Trial locations and contacts
1 site in 1 country.
France1 site
Centre Hospitalier de Martigues
Martigues, Bouches du Rhone, 13500
About this study
Official title: Etat de Lieux de l'Allaitement Maternel Exclusif et Facteurs Prédictifs au CH de Martigues
Evaluate the prevalence of exclusive breastfeeding at M3 within the Martigues CH.
Read the detailed description
After delivery, the investigating midwife or investigating pediatrician can go to the room where the new mother is installed to present the study to her. Once the patient consents, an information note will be given to her after signing a non-opposition.
The investigator or designated caregiver will produce the hetero-questionnaire in paper form to be completed depending on the patient's availability.
- Conditions
- Exclusive Breastfeeding
- Keywords
- Breast Feeding, Infant Nutrition Disorders
- Medical subject headings
- Breast Feeding, Infant Nutrition Disorders
What is being measured
The primary outcome is the main question the study is designed to answer.
Rate of maternal breastfeeding at three month (M3)
Proportion of mothers that continue exclusive breastfeeding at 3 months at Martigues Hospital
Measured: up of 3 month
Secondary outcomes (1)
Proportion of infants exclusively breastfed at discharge (after 3 days of hospitalization) M0
Proportion of mothers practicing exclusive breastfeeding from the date of delivery to the date of discharge from the maternity ward ( M0)
Measured: after 3 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted1 Jul 2025
- Study start5 Aug 2024
- Primary completion5 Aug 2025
- Study completion16 Sep 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Exclusive BreastfeedingStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Prospective
- Enrolment
- 309 participants (actual)
Sponsor and investigators
- Lead sponsor
- Centre Hospitalier de Martigues
- Sponsor type
- University, hospital or other
- Responsible party
- Sponsor
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07046741
- Sponsor's protocol ID
- CHMartigues
- Acronym
- EAME_FAP
- Status last verified
- Oct 2026
- First submitted
- 23 Jun 2025
- Last updated
- 29 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 29 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Etat de Lieux de l'Allaitement Maternel Exclusif et Facteurs Prédictifs au CH de Martigues
- ClinicalTrials.gov ID
- NCT07046741
- Acronym / sponsor ID
- EAME_FAP / CHMartigues
- Conditions
- Exclusive Breastfeeding
- Keywords
- Breast Feeding, Infant Nutrition Disorders
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 309 participants (actual)
- Lead sponsor
- Centre Hospitalier de MartiguesUniversity, hospital or other
- Study start
- 5 Aug 2024 (actual)
- Primary completion
- 5 Aug 2025 (actual)
- Study completion
- 16 Sep 2025 (actual)
- First posted
- 1 Jul 2025 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Evaluate the prevalence of exclusive breastfeeding at M3 within the Martigues CH.
Detailed description
After delivery, the investigating midwife or investigating pediatrician can go to the room where the new mother is installed to present the study to her. Once the patient consents, an information note will be given to her after signing a non-opposition.
The investigator or designated caregiver will produce the hetero-questionnaire in paper form to be completed depending on the patient's availability.
Study design
- Observational model
- Cohort
- Time perspective
- Prospective
Who may qualify
- Ages
- 18 to 60 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
- Study population
- Women practicing exclusive breastfeeding from the birth of the newborn
Key inclusion criteria (5 listed)
- Woman aged 18 and over
- Having given birth to a healthy child (or multiples) regardless of the number of weeks of amenorrhea
- Women practicing exclusive breastfeeding from the birth of the newborn
- Able to speak, read and understand French
- Having given oral consent
Key exclusion criteria (4 listed)
- Minor mothers
- Refusal of consent
- Mothers wishing to practice artificial breastfeeding upon leaving the maternity ward will be excluded in M1 and M3
- Women who have changed their mind about exclusive breastfeeding during their maternity stay will be excluded
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Rate of maternal breastfeeding at three month (M3)
Time frame: up of 3 month
Proportion of mothers that continue exclusive breastfeeding at 3 months at Martigues Hospital
1 secondary outcome
Proportion of infants exclusively breastfed at discharge (after 3 days of hospitalization) M0
Time frame: after 3 days
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 29 Oct 2026.
Related trials for Exclusive Breastfeeding
Recruiting
Effectiveness of a Counseling Program on Exclusive Breastfeeding Rates in a Primary Care Center
Growth & Development, Breastfeeding Satisfaction
Recruiting
Grandparent Breastfeeding Education and Breastfeeding Outcomes
Breastfeeding, Promotion of Exclusive Breastfeeding Through Grandparent Breastfeeding Education
Not yet recruiting
Effect of a Self-Efficacy-Based Educational Intervention on Breastfeending in Primigravid Women: A Randomized Controlled Trial
Exclusive Breastfeeding, Breastfeeding Self-Efficacy
Not yet recruiting
Impact of Chia Seeds on Human Breast Milk Composition
Obesity and Overweight, Breastfeeding, Exclusive
Not yet recruiting
Breastfeeding Education Support Tool
Breastfeeding, Exclusive, Infant Development
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Exclusive Breastfeeding, run by Centre Hospitalier de Martigues at 1 site in France.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 29 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Rate of maternal breastfeeding at three month (M3) (time frame: up of 3 month). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Oct 2026; AzTrials last refreshed its copy on 7 Nov 2026.